Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) FCF Margin (2016 - 2024)

vTv Therapeutics' FCF Margin history spans 10 years, with the latest figure at 28382.35% for Q4 2024.

  • For Q4 2024, FCF Margin changed N/A year-over-year to 28382.35%; the TTM value through Sep 2025 reached 122523.53%, down 12018393.0%, while the annual FY2024 figure was 2488.4%, N/A changed from the prior year.
  • FCF Margin for Q4 2024 was 28382.35% at vTv Therapeutics, down from 733.5% in the prior quarter.
  • Across five years, FCF Margin topped out at 7844.44% in Q2 2022 and bottomed at 77628.57% in Q3 2020.
  • The 4-year median for FCF Margin is 14557.93% (2024), against an average of 30109.08%.
  • The largest annual shift saw FCF Margin skyrocketed 8390829bps in 2020 before it crashed -7126543bps in 2021.
  • A 4-year view of FCF Margin shows it stood at 34.57% in 2020, then plummeted by -206161bps to 71300.0% in 2021, then fell by -7bps to 76444.44% in 2022, then surged by 63bps to 28382.35% in 2024.
  • Per Business Quant, the three most recent readings for VTVT's FCF Margin are 28382.35% (Q4 2024), 733.5% (Q1 2024), and 76444.44% (Q4 2022).